Results 161 to 170 of about 207,050 (299)

Prostate-specific membrane antigen radioguided surgery in prostate cancer: A narrative review. [PDF]

Cent European J Urol
Chuchra P, Karwacki J, Matsukawa A, Borek B, Rynkiewicz T, Tayara O, Małkiewicz B, Rajwa P, Paradysz A, Zyczkowski M.   +9 more
europepmc   +1 more source

Engineering exosomal cargo loading via endogenous molecular pathways: Strategies to enhance therapeutic potential

Interdisciplinary Medicine, EarlyView.
This review illustrates how scientists engineer exosomes by hijacking the cell's own cargo‐sorting machinery. These strategies efficiently load therapeutic molecules into natural vesicles, creating powerful next‐generation drug delivery systems (Created with BioGDP.com).
Huanrong Zhu, Chenning Zhang, Shihan Ma, Zhanxue Xu, Cailing Liang, Fang Cheng, Hongbo Chen   +6 more
wiley   +1 more source

Reply to "Salvage radiotherapy for recurrent prostate cancer diagnosed by prostate-specific membrane antigen positron emission tomography imaging". [PDF]

J Chin Med Assoc
Lan TL, Lin KH, Wei TC, Hu YW, Lai TY, Kang YM, Chung HJ, Shen SH, Liu YM.   +8 more
europepmc   +1 more source

Prostate-specific membrane antigen (PSMA) [PDF]

Science-Business eXchange, 2009
openaire   +1 more source

SUMOylation regulates tumorigenesis and progression: Molecular mechanisms and therapeutic applications

Interdisciplinary Medicine, EarlyView.
SUMOylation, a dynamic post‐translational modification, acts as a master regulator at the heart of tumor malignancy. Our work delineates how the SUMOylation cycle—mediated by E1/E2/E3 enzymes and reversed by SENPs—orchestrates multiple hallmarks of cancer. The central pathway converges on three critical pathological axes: 1.
Yimao Wu, Zichang Chen, Yinting Hu, Gokhan Zengin, Qian Zhang, Meng‐Yao Li, Wenlong Sun   +6 more
wiley   +1 more source

Salvage radiotherapy for recurrent prostate cancer diagnosed by prostate-specific membrane antigen positron emission tomography imaging. [PDF]

J Chin Med Assoc
Chang WH, Yang ST.
europepmc   +1 more source

Fundamental Research Into and Clinical Translation of Tumor Irreversible Electroporation‐Based Ablation Therapy Devices

iRADIOLOGY, EarlyView.
This review focuses on irreversible electroporation (IRE), presenting its tumor ablation mechanism, characteristics of related clinical devices, and progress in basic experimental devices. ABSTRACT Irreversible electroporation (IRE) is an emerging tumor ablation technique that induces permanent damage to cellular membranes through the application of ...
Haoyu Liu, Wenyuan Ma, Fan Xu, Lei Xu, Chengyue Zhang, Wenjing Lou, Liting Xie, Tianan Jiang   +7 more
wiley   +1 more source

Sparse-view reconstruction and noise reduction in 99m Tc-prostate specific membrane antigen prostate imaging. [PDF]

Nucl Med Commun
Jamaati S, Dorri Giv M, Hong X, Sadeghi R, Saber Tanha A, Noroozi M, Arabi H.   +6 more
europepmc   +1 more source

Clinical Advantages of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography/Magnetic Resonance in Radiotherapy: A Narrative Review

iRADIOLOGY, EarlyView.
Review the clinical application of PET multimodal imaging and compare its clinical advantages. ABSTRACT Positron emission tomography (PET)–based multimodal imaging, including PET/computed tomography (PET/CT) and PET/magnetic resonance (PET/MR), plays an increasingly important role in precision radiotherapy by integrating metabolic and anatomical ...
Yingze Fu, Jyh‐Cheng Chen, Zhongying Ma, Junchi Ma, Jianfeng Qiu   +4 more
wiley   +1 more source

Implications for Radiation Microboosting Based on Pathology Correlations With Prostate-Specific Membrane Antigen and Multiparametric Magnetic Resonance Imaging Findings. [PDF]

Adv Radiat Oncol
Farmer A, Ballas LK, Sandler HM, Kim S, Nguyen AT, Kamrava M.   +5 more
europepmc   +1 more source